Clinical Trial Update: Feasibility of Doctors' Rooms-based Infusion of Zoledronic Acid [Phase 4]

View source ↗

Summary

Phase 4 feasibility trial evaluating doctors' room infusion of zoledronic acid for osteoporosis has completed, sponsored by Novartis Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Osteoporosis | Phase 4 | Status: COMPLETED